{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:22:38Z","timestamp":1786998158020,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["COVID19RF-008"],"award-info":[{"award-number":["COVID19RF-008"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["COVID19RF-001"],"award-info":[{"award-number":["COVID19RF-001"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["COVID19RF3-0060"],"award-info":[{"award-number":["COVID19RF3-0060"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.xcrm.2022.100793","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T02:17:09Z","timestamp":1665022629000},"page":"100793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["A comparative characterization of SARS-CoV-2-specific T\u00a0cells induced by mRNA or inactive virus COVID-19 vaccines"],"prefix":"10.1016","volume":"3","author":[{"given":"Joey Ming Er","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou Kit","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smrithi","family":"Hariharaputran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Sing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh Lian","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chien","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Le Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100793_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(21)02046-8","article-title":"Considerations in boosting COVID-19 vaccine immune responses","volume":"398","author":"Krause","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2022.100793_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/d41586-021-02796-w","article-title":"China's COVID vaccines have been crucial - now immunity is waning","volume":"598","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib3","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1038\/s41467-022-31485-z","article-title":"Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents","volume":"13","author":"Rosa Duque","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100793_bib4","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T\u00a0cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100793_bib5","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet. Microbe"},{"key":"10.1016\/j.xcrm.2022.100793_bib6","article-title":"Persistence of immune responses to the Sinopharm\/BBIBP-CorV vaccine","volume":"10","author":"Jeewandara","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.xcrm.2022.100793_bib7","doi-asserted-by":"crossref","first-page":"103904","DOI":"10.1016\/j.ebiom.2022.103904","article-title":"Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong","volume":"77","author":"Peng","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2022.100793_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1473-3099(21)00681-2","article-title":"Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials","volume":"22","author":"Zeng","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100793_bib9","doi-asserted-by":"crossref","first-page":"816778","DOI":"10.3389\/fmicb.2022.816778","article-title":"Inactivated vaccines against SARS-CoV-2: neutralizing antibody titers in vaccine recipients","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2022.100793_bib10","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S2666-5247(21)00177-4","article-title":"Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19","volume":"2","author":"Lim","year":"2021","journal-title":"Lancet. Microbe"},{"key":"10.1016\/j.xcrm.2022.100793_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T\u00a0cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100793_bib12","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib13","doi-asserted-by":"crossref","first-page":"eabl5344","DOI":"10.1126\/sciimmunol.abl5344","article-title":"BNT162b2 vaccination induces durable SARS-CoV-2-specific T\u00a0cells with a stem cell memory phenotype","volume":"6","author":"Guerrera","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib14","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody persistence through 6 Months after the second dose of mRNA-1273 vaccine for covid-19","volume":"384","author":"Doria-Rose","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib15","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/biomedicines10020338","article-title":"Comparison of neutralizing antibody responses at 6 Months post vaccination with BNT162b2 and AZD1222","volume":"10","author":"Terpos","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2022.100793_bib17","first-page":"ciac288","article-title":"Comparative effectiveness of mRNA and inactivated whole virus vaccines against COVID-19 infection and severe disease in Singapore","volume":"12","author":"Premikha","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100793_bib18","doi-asserted-by":"crossref","first-page":"eabo1303","DOI":"10.1126\/sciimmunol.abo1303","article-title":"Understanding T\u00a0cell responses to COVID-19 is essential for informing public health strategies","volume":"7","author":"Vardhana","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib19","doi-asserted-by":"crossref","first-page":"eabj1750","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","volume":"6","author":"Geers","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib20","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","article-title":"Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T\u00a0cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib22","doi-asserted-by":"crossref","first-page":"n2015","DOI":"10.1136\/bmj.n2015","article-title":"Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study","volume":"374","author":"Ranzani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.xcrm.2022.100793_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M21-3509","article-title":"Effectiveness of inactivated COVID-19 vaccines against illness caused by the B.1.617.2 (Delta) variant during an outbreak in guangdong, China : a cohort study","volume":"175","author":"Kang","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijid.2022.01.030","article-title":"Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China","volume":"116","author":"Hu","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100793_bib25","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100793_bib26","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41423-021-00730-8","article-title":"SARS-CoV-2-specific T\u00a0cell immunity to structural proteins in inactivated COVID-19 vaccine recipients","volume":"18","author":"Deng","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib28","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: the key to more effective vaccines?","volume":"9","author":"Ho","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib29","doi-asserted-by":"crossref","first-page":"e152379","DOI":"10.1172\/JCI152379","article-title":"Rapid measurement of SARS-CoV-2 spike T\u00a0cells in whole blood from vaccinated and naturally infected individuals","volume":"131","author":"Tan","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100793_bib30","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.str.2020.10.001","article-title":"The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET","volume":"28","author":"Liu","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.xcrm.2022.100793_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib32","doi-asserted-by":"crossref","first-page":"12038","DOI":"10.1038\/s41598-022-16097-3","article-title":"Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants","volume":"12","author":"Vadrevu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100793_bib33","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T\u00a0cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib36","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T\u00a0cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100793_bib37","doi-asserted-by":"crossref","first-page":"eabq7647","DOI":"10.1126\/sciimmunol.abq7647","article-title":"CD8 T\u00a0cells contribute to vaccine protection against SARS-CoV-2 in macaques","volume":"9","author":"Liu","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib39","doi-asserted-by":"crossref","first-page":"e20202617","DOI":"10.1084\/jem.20202617","article-title":"Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection","volume":"218","author":"Le Bert","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T\u00a0cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100793_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100793_bib42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","article-title":"Unbiased screens show CD8(+) T\u00a0cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein","volume":"53","author":"Ferretti","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100793_bib43","article-title":"A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques","volume":"9","author":"Harris","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2022.100793_bib44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Cutting edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib45","doi-asserted-by":"crossref","first-page":"827605","DOI":"10.3389\/fimmu.2022.827605","article-title":"DNA vaccines expressing the Envelope and Membrane proteins provide partial protection against SARS-CoV-2 in mice","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib46","doi-asserted-by":"crossref","first-page":"e159500","DOI":"10.1172\/JCI159500","article-title":"Favorable vaccine-induced SARS-CoV-2 specific T\u00a0cell response profile in patients undergoing immune-modifying therapies","volume":"132","author":"Qui","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100793_bib47","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T\u00a0cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41564-022-01123-x","article-title":"BNT162b2-induced memory T\u00a0cells respond to the Omicron variant with preserved polyfunctionality","volume":"7","author":"Jung","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2022.100793_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib50","doi-asserted-by":"crossref","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100793_bib52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100793_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.crimmu.2022.08.005","article-title":"From Alpha to omicron: the response of T\u00a0cells","volume":"3","author":"Grifoni","year":"2022","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib54","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100793_bib55","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2022.100793_bib56","first-page":"104","article-title":"Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients","volume":"3","author":"Khoo","year":"2022","journal-title":"Med (N Y)"},{"key":"10.1016\/j.xcrm.2022.100793_bib57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cmi.2021.10.006","article-title":"Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine","volume":"28","author":"Chen","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.xcrm.2022.100793_bib58","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1038\/s41598-018-36703-7","article-title":"Induction of human T-cell and cytokine responses following vaccination with a novel influenza vaccine","volume":"8","author":"Skibinski","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100793_bib59","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.vaccine.2016.12.031","article-title":"An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T\u00a0cell response in healthy adult volunteers","volume":"35","author":"Wijaya","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2022.100793_bib60","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8(+) T\u00a0cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100793_bib61","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.abg8985","article-title":"Clonal analysis of immunodominance and cross-reactivity of the CD4 T\u00a0cell response to SARS-CoV-2","volume":"372","author":"Low","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib62","doi-asserted-by":"crossref","first-page":"eabh1823","DOI":"10.1126\/science.abh1823","article-title":"Cross-reactive CD4(+) T\u00a0cells enhance SARS-CoV-2 immune responses upon infection and vaccination","volume":"374","author":"Loyal","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib63","doi-asserted-by":"crossref","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T\u00a0cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100793_bib64","doi-asserted-by":"crossref","first-page":"143380","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less-severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100793_bib65","first-page":"682","article-title":"Early T\u00a0cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset","volume":"2","author":"Kalimuddin","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.xcrm.2022.100793_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T\u00a0cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100793_bib67","first-page":"1","article-title":"The activation of bystander CD8(+) T\u00a0cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib68","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s12276-020-00486-7","article-title":"Bystander CD4(+) T\u00a0cells: crossroads between innate and adaptive immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2022.100793_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","volume":"310","author":"Sette","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2022.100793_bib70","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T\u00a0cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100793_bib71","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","article-title":"Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study","volume":"22","author":"McMenamin","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100793_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-022-00373-7","article-title":"Robust induction of B cell and T\u00a0cell responses by a third dose of inactivated SARS-CoV-2 vaccine","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Discov."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:53:41Z","timestamp":1762988021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666379122003482"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100793","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative characterization of SARS-CoV-2-specific T\u00a0cells induced by mRNA or inactive virus COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100793"}}